Lamotrigine Tablet
Product Images NDC 70518-2406

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-2406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2d955155 686d 40cd 898e Df7d760247a5 789 2

Lamotrigine oral tablets in four strengths and shapes: 25 mg white rectangular tablets marked 'U U 111'; 100 mg white triangular tablets marked 'U U 112'; 150 mg white triangular tablets marked 'U U 113'; and 200 mg light blue triangular tablets marked 'U U 114'.*

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 200 mg oral tablet label. The package contains 30 tablets. Label shows the product name with strength highlighted, NDC 70518-2406-00, and specifies repackaging by RemedyRepack Inc. Directions advise seeing the package insert for use. Storage instructions include 20-25°C with excursions permitted to 15-30°C.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01

Chemical structure of lamotrigine, showing the molecular arrangement including chlorine atoms and nitrogen-containing rings.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02

A Kaplan-Meier failure probability plot showing the comparison between Lamotrigine and Placebo over approximately 100 weeks. The y-axis represents failure probability percentage, while the x-axis denotes time in weeks. The graph includes censorship markers indicating censored data points.*

FDA Label Image

Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03

A Kaplan-Meier failure probability graph showing failure probability (%) on the vertical axis over time in weeks on the horizontal axis. The chart compares two groups labeled Placebo and Lamotrigine, with censored data points indicated. The Placebo group shows a higher failure probability over time compared to the Lamotrigine group.*

FDA Label Image

Mm2 (Lamotrigine 200mg 70518 2406 01)

Lamotrigine 200 mg oral tablet single unit label by RemedyRepack Inc. The label shows the proprietary and nonproprietary name, strength, dosage form, quantity of 1 tablet, and repackaging information. It includes storage instructions and a QR code, with manufacturer Unichem Pharma Inc. noted.*

FDA Label Image

Lamotrigine 200mg 70518 2406 02

Lamotrigine 200 mg oral tablet, packaged in a bottle of 100 tablets. The label shows the product name with strength prominently displayed on a purple background. It is labeled for prescription use only and repackaged by RemedyRepack Inc. Additional information includes the NDC number 70518-2406-02 and manufacturer Unichem Pharma Inc., Hasbrouck Heights, NJ.*

FDA Label Image

Lamotrigine 200mg 70518 2406 03

Lamotrigine 200 mg oral tablet packaging label showing a single tablet quantity. The label includes the NDC 70518-2406, manufacturer Unichem Pharma Inc., and repackager Remedy Repack Inc. Directions advise to see package insert. The label emphasizes prescription use and storage instructions at 20-25°C with permitted excursions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.